30
Participants
Start Date
March 31, 2015
Primary Completion Date
May 31, 2019
Study Completion Date
May 31, 2020
Intravenous Immunoglobulin
The decision to treat with IVIg will be entirely at the discretion of the patient's treating physician.
Columbia University Medical Center, New York
University of Virginia, Charlottesville
Neurology at John's Creek, Johns Creek
University of Minnesota, Minneapolis
Northwestern University, Chicago
University of Kansas Medical Center, Kansas City
Dartmouth-Hitchcock Medical Center/Dartmouth Geisel School of Medicine, Lebanon
Collaborators (1)
BriovaRx Infusion Services
INDUSTRY
CSL Behring
INDUSTRY
University of Minnesota
OTHER